Loading...
New treatments for myasthenia: a focus on antisense oligonucleotides
Autoimmune myasthenia gravis (MG) is a neuromuscular disorder caused by autoantibodies directed against the acetylcholine receptor (AChR). Current symptomatic therapy is based on acetylcholinesterase (AChE) drugs. The available long-term current therapy includes steroids and other immunomodulatory a...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3546757/ https://ncbi.nlm.nih.gov/pubmed/23341732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S25716 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|